The ARB found that Unilever’s packaging had acquired substantial advertising goodwill and that Epic Foods had exploited this by imitating key visual elements, particularly after Hellmann’s ...
Many recent and ongoing cardiovascular morbidity and mortality clinical trials were designed to evaluate the potential advantages of ARBs in patients with hypertensive heart disease or renal disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback